Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Using ultrasound to guide endometrial biopsies for post-menopausal bleeding

Official title: Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding: Randomised Controlled Trial.

Run by Imperial College Healthcare NHS Trust · NCT06501846 · Data updated 2026-11-12

This study is testing if using ultrasound to guide endometrial biopsies can help women with post-menopausal bleeding get better tissue samples and avoid more invasive procedures.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment92 (estimated)
SponsorImperial College Healthcare NHS Trust
Academic / other
Locations1 site (London)
StatusRecruiting
StartedJuly 23, 2024
Main results expectedJuly 23, 2027
Study endsJuly 23, 2027
Registry record updatedJuly 15, 2024
Trial IDNCT06501846 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older who are experiencing post-menopausal bleeding and require an endometrial biopsy.

Probably not a fit

Patients with known focal endometrial pathology or a history of endometrial cancer or hyperplasia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effectiveness of using transabdominal ultrasound guidance during Pipelle® endometrial biopsies for women experiencing post-menopausal bleeding. The aim is to improve the success rate of obtaining adequate tissue samples for laboratory assessment, thereby reducing the need for more invasive procedures. Participants will be randomly assigned to receive either ultrasound-guided or standard biopsies. The study focuses on women with thickened endometrial linings who require biopsies to rule out endometrial cancer or hyperplasia.

Why it matters

Potential benefit: If successful, this approach could lead to more accurate diagnoses and fewer invasive procedures for women with post-menopausal bleeding.

How similar studies have gone: Other studies have shown promise in using ultrasound guidance for biopsies, suggesting this approach may enhance diagnostic accuracy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients with post-menopausal bleeding who require an endometrial biopsy.

Further details:

* Post-menopausal bleeding is defined as bleeding one year after a woman's last menstrual period or bleeding six months after starting continuous combined hormone replacement therapy.
* There is no upper age limit, however all patients must be 18 or above.

Strict ultrasound criteria will be followed:

* Endometrium ≥5mm: this is the current cut off used by Imperial College Healthcare NHS Trust for a biopsy to be indicated in the context of post-menopausal bleeding.
* Smooth, homogenous endometrium with a clearly defined border.

Exclusion Criteria:

* Focal endometrial pathology (including but not limited to endometrial polyps, type 0-2 fibroids, uterine septa and other uterine structural abnormalities).
* Suspicion of non-benign myometrial pathology.
* History of endometrial cancer or endometrial hyperplasia.
* History of cervical cancer.
* Virgo intacta.
* Inability to tolerate vaginal examination.
* Inability to consent.
* The denial or withdrawal of informed written consent.

Where it's running

  • Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare Trust
    London, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Joseph Yazbek, MD — Imperial College Healthcare Trust
  • Study coordinator: Joseph Yazbek, MD
  • Email: joseph.yazbek@nhs.net
  • Phone: 02033133570

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.